Posaconazole Tablet, Delayed Release
Product Images NDC 0527-2133

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 0527-2133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6369970a 9b52 4fac 990f B470aa3057aa 1

Chemical structure of posaconazole, the active ingredient in POSACONAZOLE 100 mg delayed-release tablets by Lannett Company Inc. The diagram shows the molecular arrangement of atoms and bonds characteristic of posaconazole.*

FDA Label Image

6369970a 9b52 4fac 990f B470aa3057aa 1000 Tab Label

Posaconazole Delayed-Release Tablets 100 mg label from Lannett Company Inc. The label indicates 1000 tablets packaged with instructions to store at 20° to 25°C, with permitted excursions to 15° to 30°C. It states that tablets are not interchangeable with oral suspension formulations due to dosing differences. Includes distributor and manufacturer details and a barcode.*

FDA Label Image

6369970a 9b52 4fac 990f B470aa3057aa 24 Tab Label

Label for Posaconazole Delayed-Release Tablets 100 mg by Lannett Company Inc. The label indicates oral tablets in a package containing 24 tablets (2 x 12). Storage instructions and a warning to keep the medication out of children's reach are included, along with manufacturer details and an area designated for printing LOT, expiration, and serialization information.*

FDA Label Image

6369970a 9b52 4fac 990f B470aa3057aa 60 Tab Label

Label for Posaconazole delayed-release tablets, 100 mg, oral dosage form. The label indicates prescription-only status and a package count of 60 tablets. It includes storage instructions, manufacturer (Haimei Pharmaceutical, China), distributor (Lannett Company Inc.), and a barcode. The label cautions that Posaconazole oral suspension and delayed-release tablets are not interchangeable due to dosing differences.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.